Edition:
United States

Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

46.65USD
25 Sep 2018
Change (% chg)

$-0.28 (-0.60%)
Prev Close
$46.93
Open
$47.18
Day's High
$48.37
Day's Low
$46.60
Volume
520,373
Avg. Vol
754,588
52-wk High
$50.44
52-wk Low
$27.23

Chart for

About

Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is... (more)

Overall

Beta: 0.51
Market Cap(Mil.): $3,328.29
Shares Outstanding(Mil.): 70.92
Dividend: --
Yield (%): --

Financials

  MYGN.O Industry Sector
P/E (TTM): 34.33 48.29 32.55
EPS (TTM): 1.37 -- --
ROI: 9.35 8.54 12.80
ROE: 11.16 12.26 14.92

BRIEF-Myriad Genetics Reports Q3 GAAP Earnings Per Share $0.16

* MYRIAD GENETICS REPORTS FISCAL THIRD-QUARTER 2018 FINANCIAL RESULTS

May 08 2018

BRIEF-Myriad Receives Pre Market Approval For Its Bracanalysis Diagnostic System In Japan

April 2 Myriad Genetics Inc - ‍Astrazeneca And Merck Are Seeking Approval Of Lynparza In Japan For Treating Patients With Brca :

Apr 02 2018

Earnings vs. Estimates